ROSSI, FRANCESCA GAIA
 Distribuzione geografica
Continente #
EU - Europa 3.227
NA - Nord America 1.350
AS - Asia 809
SA - Sud America 74
OC - Oceania 7
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.471
Nazione #
DE - Germania 1.402
US - Stati Uniti d'America 1.300
GB - Regno Unito 822
CN - Cina 377
IT - Italia 237
SE - Svezia 237
SG - Singapore 153
FI - Finlandia 145
RU - Federazione Russa 113
TR - Turchia 93
UA - Ucraina 68
IN - India 62
KR - Corea 61
EU - Europa 54
FR - Francia 52
IE - Irlanda 49
CA - Canada 43
NL - Olanda 41
BR - Brasile 35
CO - Colombia 30
HK - Hong Kong 17
ID - Indonesia 11
JP - Giappone 10
ES - Italia 9
GR - Grecia 8
IL - Israele 6
MX - Messico 6
PL - Polonia 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
VN - Vietnam 5
AU - Australia 4
BE - Belgio 4
CH - Svizzera 4
PT - Portogallo 4
RO - Romania 4
HU - Ungheria 3
NZ - Nuova Zelanda 3
PH - Filippine 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
AR - Argentina 2
BG - Bulgaria 2
BO - Bolivia 2
HR - Croazia 2
TH - Thailandia 2
CL - Cile 1
EG - Egitto 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 5.524
Città #
Frankfurt am Main 881
Southend 767
Munich 177
Chandler 140
Beijing 121
Singapore 108
Seattle 106
Helsinki 102
Milan 93
Princeton 80
Wilmington 78
Fairfield 71
Mountain View 51
Dublin 49
Jacksonville 45
Ashburn 43
Somerville 42
Dearborn 40
Redmond 39
Council Bluffs 36
Nanjing 35
Toronto 35
Grafing 31
Bogotá 28
Sakarya 28
Woodbridge 28
Andover 26
Berlin 24
Serra 24
Santa Clara 22
Boardman 20
Shanghai 20
Bengaluru 18
Houston 17
Des Moines 14
Guangzhou 13
Hamburg 13
Jinan 12
Nürnberg 12
Shenyang 12
Eitensheim 11
Odernheim 11
Cambridge 10
Hong Kong 10
Jyväskylä 10
Los Angeles 10
Redwood City 10
Changsha 9
Falls Church 9
Kiez 9
Phoenix 9
Hangzhou 8
Hanover 8
Kunming 8
Nanchang 8
Turin 8
Ann Arbor 7
Athens 7
Bitonto 7
Hebei 7
London 7
San Diego 7
Columbus 6
Jakarta 6
New York 6
Pisa 6
Roxbury 6
Chongqing 5
Foshan 5
Fuzhou 5
Hefei 5
Hyderabad 5
Portici 5
Rome 5
Saint Petersburg 5
San Jose 5
Tel Aviv 5
Auburn Hills 4
Dallas 4
Dong Ket 4
Mumbai 4
Naples 4
Ottawa 4
Scranton 4
Taizhou 4
Tianjin 4
Bonita 3
Brookline 3
Brussels 3
Budapest 3
Chicago 3
Costa Mesa 3
Frontone 3
Gwanak-gu 3
Jiaxing 3
Kolonets 3
Kwai Chung 3
Leawood 3
Mainz 3
Montevideo 3
Totale 3.849
Nome #
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571 364
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience 328
Prognostic scoring system for IGG and IGA monoclonal gammopathies of undetermined significance 299
Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. 290
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma 271
Fludarabine, cyclophosphamide and rituximab in patients with advanced untreated indolent B-cell non-follicular lymphomas : final result of phase two study of Fondazione Italiana Linfomi (FIL) 256
Post-transplant lymphoproliferative disorders in liver and kidney recipients : a single institution experience 238
Indolent B-cell lymphomas treated upfront with antiviral therapy : a series of 13 patients 225
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 223
Retrospective analysis of salvage regimen for relapsed or refractory classical Hodgkin lymphoma 197
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors 195
Frontline treatment with the combination fludarabine-cyclophosphamide in low-grade non-follicular non-Hodgkin lymphoma : a long term updating of GISL LL02 trial 190
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 180
Role of positron emission tomography in indolent non Hodgkin lymphomas 175
IgG and IgA Monoclonal Gammopathies of Undetermined Significance (MGUS) at Low Risk of Evolution : Proposal and Validation of a Prognostic Scoring System 171
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias 166
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance 164
Front-line treatment of low-grade non-follicular non-hodgkin lymphoma : final report of GISL LL02 trial 146
ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma 136
STI571 administered to chronic myeloid leukemia (CML) patients inhibits cell proliferation, induces apoptosis and initially causes partial inhibition of BCR/ABL autophosphorylation 134
Low risk IgG Monoclonal Gammopathy of undetermined significance (MGUS) : proposal and validation of a prognostic scoring system 132
Treatment with hydroxyurea as single agent does not increase the risk of second malignancies in essential thrombocytopenia patients 127
Final report 50F GISL LL02 trials for thr treatment of low-grade non- follicular non- Hodgkin lymphoma, at diagnosis 126
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade 124
Febrile Neutropenia Risk Assesment and Granulocyte-Colony Stimulating Factor Support in Patients with Diffuse Large B Cell Lymphoma Receiving R-CHOP Regimens 123
Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of diesease 109
Second malignancies in essential thrombocytosis : a retrospective analysis of 331 patients from a single institution 106
Alpha 1 acid glycoprotein (AGP) binds to STI571 and alters its tissue distribution and intracellular concentrations 102
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients 98
Differences between In Vivo and In Vitro Sensitivity to Imatinib of Bcr/Abl+ Cells Obteined from Leukemic Patients 96
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 91
Natural and assisted conceptions in male cancer recipients of hematopoietic cell transplantation who stored their semen for fertility preservation 90
Sex determination and differentiation in Asparagus officinalis L 50
Wait and see: a case of EBV + cutaneous extranodal NK/T-type lymphoma with indolent behaviour 26
Normalization of duodenal mucosa after treatment with Janus kinase (JAK) inhibitor in refractory celiac disease type 2 3
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD 1
Totale 5.752
Categoria #
all - tutte 12.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.945


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 0 0 0 0 0 0 0 32 72 23 2
2020/2021554 30 58 49 6 37 19 15 29 84 25 171 31
2021/2022394 45 9 15 9 28 36 41 21 84 25 28 53
2022/2023526 64 54 49 49 67 97 10 23 64 3 28 18
2023/2024863 16 28 18 29 61 47 120 112 54 117 129 132
2024/2025958 116 130 100 142 52 74 119 129 96 0 0 0
Totale 5.752